Assessment of Screening Criteria and Prognosis in Lung Cancer Patients in South Korea
-
By
-
Yeon Wook Kim
-
Tae Ho Yoon
-
Kyeong Im Kwak
-
Minji Han
-
Eung Joo Park
-
Choon-Taek Lee
-
July 21, 2026
Clinical Scorecard: Assessment of Screening Criteria and Prognosis in Lung Cancer Patients in South Korea
At a Glance
| Category | Detail |
|---|
| Condition | Lung Cancer |
| Key Mechanisms | Early detection through effective screening is critical for reducing mortality. |
| Target Population | Individuals aged 54 to 74 years with a smoking history of 30 pack-years or more. |
| Care Setting | Population-based cohort study in South Korea. |
Key Highlights
- Lung cancer is the leading cause of cancer-related mortality worldwide.
- Low-dose chest computed tomography (LDCT) screening is effective in reducing lung cancer mortality.
- Current screening criteria may miss approximately 50% of lung cancer cases.
- The national screening program in South Korea targets current smokers aged 54 to 74 years.
- Research is ongoing to evaluate screening strategies for individuals with no smoking history.
Guideline-Based Recommendations
Diagnosis
- Eligibility for screening should be based on age and smoking exposure.
Management
- Screening is recommended for individuals aged 50 to 80 years with 20 pack-years or more of smoking.
Monitoring & Follow-up
- Follow-up of patients diagnosed with lung cancer until death or end of study period.
Risks
- Indiscriminate expansion of screening may lead to overdiagnosis.
Patient & Prescribing Data
Individuals diagnosed with lung cancer in South Korea from 2013 to 2018.
Data linked from multiple sources to assess demographic characteristics and health screening results.
Clinical Best Practices
- Utilize comprehensive databases for demographic and clinical assessments.
- Adhere to established screening criteria for lung cancer.
Related Resources & Content
